NAC 900 mg
Natural health product licensed in Canada
- Licence holder
- Nestle Canada Inc. dba (Atrium Innovations/Genestra Brands/Pure Encapsulations/Garden of Life Canada/Trophic Canada/SISU/Wobenzym/Bountiful Canada Vitamins/Nature's Bounty/Vital Proteins Canada)
- NPN or DIN-HM
- 80067344
- Status
- Active licence
- Licence date
- 3 March 2016
- Revision date
- 12 July 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 900 milligramme | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, Palmitate d'ascorbyle, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 day ; maximum: 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants. Supports glutathione production which plays a role in normal, healthy detoxification processes. N-acetyl-L-Cysteine is a potent antioxidant for the maintenance of good health in individuals under oxidative stress. Helps support immune functions. To help relieve symptoms of chronic bronchitis. NAC (n-acetylcysteine) relieves the symptoms of chronic bronchitis. Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps to reduce the severity and frequency of influenza-like symptoms in adults over 65 years of age and in those suffering from non-respiratory chronic degenerative diseases. Helps reduce/relieve the frequency of exacerbations/symptoms (ie: reduce sputum (mucus) buildup, reduce difficulty of expectoration of sputum (mucus)) in individuals with chronic bronchitis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80067344
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging